EESO Enzyme Environmental Solutions Inc (CE)

Enzyme Environmental Solutions, Inc. (PINKSHEETS: EESO) CEO, Jared Hochstedler, and President, Mark Murphy, met recently to prepare a statement to shareholders regarding final decisions on the pending buyout offer, Belmont lawsuit and a rumored discrepancy between EESO and its exclusive retail partner, Wow Green International, LLC. Mark Murphy believes, "These issues have become unnecessarily distracting to our company's momentum. Jared and I feel that clarification on these matters will allow shareholders to focus on our progress in sales and customer acquisition both domestically and internationally."

Hochstedler informs that, "All existing buyout offers have been turned down. We feel that the original offer and counter-offer from the Lees were attractive, but only a sign of bigger things to come. This company has made tremendous strides in the last few months in terms of attracting new customer interest on the industrial and food-service commercial arenas. The groundwork laid by Mark Murphy and our National Sales Director, Jeffrey Smith, has EESO poised as one of the most progressive publicly traded micro-cap Green companies in existence. Our ferment-based formulas are second to none. Many have tried to duplicate or modify and none have come close to the cost-efficiency and effectiveness of our nature-based products; nor do they have the research teams in place to ensure a multitude of applications in a world where governments are going Green. Even niche industries are becoming multi-faceted with a need for a variety of solutions that EESO will provide."

Hochstedler is confident the company is well poised among its competitors. "Last year was an impressive year overall, but I can't say we haven't been vulnerable in certain areas. What I can say is that we recognize this and have taken appropriate measures. We will continue to progress consistently as we did before any talk of buyouts, which I feel, may have caused a distraction from our focus on the company, its products, its employees and its growth from within as a star player in the biotech revolution. Our formulas and their applications are protected by comprehensive confidentiality and non-compete agreements with everyone that has worked with or for the company. We will protect and nourish our golden goose with the respect she deserves and anything that threatens that process will be given due attention."

Some of the disruption in investor confidence was caused by a lawsuit, made public by an in-house press release from plaintiff, Belmont Partners. "We have paid for our publicly traded entity in full as agreed, contrary to claims made by Belmont," states Hochstedler. "Our attorneys believe the lawsuit to be unfounded and we are submitting documentation to courts in Virginia asking the judge to dismiss the case. We are confident this will be a non-issue."

"Lastly, there have been rumors regarding Wow Green International and the status of our relationship. Unfortunately, Wow Green has been remiss in fulfilling obligations in regards to outstanding receivables for product that was ordered by Wow Green, manufactured and shipped by Enzyme Environmental and, to the best of our knowledge, sold for profit by Wow Green. We believe this matter will be resolved amicably and I feel that EESO and its shareholders will be in profitable good-standing as we have taken what we believe to be appropriate action in this matter," states Hochstedler.

Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact: Newbauer Media Relations Email: mark@enzymeconsultants.com